Cafaminol

Cafaminol
Clinical data
Trade names	Rhinetten, Rhinoptil
Other names	Methylcoffanolamine; 8-[(2-Hydroxyethyl)(methyl)amino]caffeine
ATC code	None;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 8-[(2-hydroxyethyl)(methyl)amino]-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione;
CAS Number	30924-31-3;
PubChem CID	35685;
ChemSpider	32824;
UNII	0L1S25NC1L;
ChEMBL	ChEMBL2104570;
CompTox Dashboard (EPA)	DTXSID60184916 ;
ECHA InfoCard	100.045.795
Chemical and physical data
Formula	C11H17N5O3
Molar mass	267.289 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C2N(c1nc(n(c1C(=O)N2C)C)N(CCO)C)C;
	InChI InChI=1S/C11H17N5O3/c1-13(5-6-17)10-12-8-7(14(10)2)9(18)16(4)11(19)15(8)3/h17H,5-6H2,1-4H3; Key:ZGNRRVAPHPANFI-UHFFFAOYSA-N;

Cafaminol (brand names Rhinetten, Rhinoptil), also known as methylcoffanolamine, is a vasoconstrictor and anticatarrhal of the methylxanthine family related to caffeine which is used as a nasal decongestant in Germany.^[1]^[2]^[3]^[4]^[5]^[6] It was introduced in 1974 and was still in use as of 2000.^[3]^[2]

Quick facts Clinical data, Trade names ...

References